Skip to main content
OpenTrials

Clinical trial condition

Hypergammaglobulinemia

Explore clinical trials studying Hypergammaglobulinemia. Study availability and eligibility vary by location and protocol.

137 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hypergammaglobulinemia trial results

Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592

Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details
Recruiting

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

NCT07214324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • Istituto Ortopedico Rizzoli IRCCS Bologna, Italy
  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco" Catania, Italy
  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone" Palermo, Italy
  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
View Trial Details
Recruiting

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

NCT06383143

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +17 more
Locations
  • Azienda Ospedaliera Policlinico Consorziale Bari, Italy
  • Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco Catania, Italy
  • Fondazione Irccs Policlinico San Matteo Pavia, Italy
  • EMATOLOGIA - Città della Scienza e Salute - Torino Torino, Italy
View Trial Details
Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT05640843

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Emory University (Data Collection Only) Atlanta, Georgia, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma

NCT07069751

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • IRCCS Ospedale San Raffaele Milan, Milano, Italy
  • Ospedale Giovanni XXIII Policlinico di Bari Bari, Italy
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
View Trial Details

Related conditions